Search

Author/Creator Miller, M

1. Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. (27th April 2018)

Authors:
Hortobagyi, G N; Stemmer, S M; Burris, H A; Yap, Y S; Sonke, G S; Paluch-Shimon, S; Campone, M; Petrakova, K; Blackwell, K L; Winer, E P; Janni, W; Verma, S; Conte, P; Arteaga, C L; Cameron, D A; Mondal, S; Su, F; Miller, M; Elmeliegy, M; Germa, C
Journal:
Annals of oncology
Issue:
Volume 29:Number 7(2018)
Page Start:
1541
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 39ORibociclib (RIB) + non-steroidal aromatase inhibitor (NSAI) + goserelin in premenopausal Asian women with hormone-receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): Results from the randomized phase III MONALEESA-7 study. (25th November 2018)

Authors:
Im, S-A; Sohn, J; Tripathy, D; Chow, L; Lee, K S; Jung, K H; Babu, G; Im, Y-H; El Saghir, N; Liu, M-C; Diaz-Padilla, I; Alam, J; Kong, O; Miller, M; Lu, Y-S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 0737 Obstructive Sleep Apnea: A Distinct Physiological Phenotypic Risk Factor in older adults with Cognitive decline and Alzheimer's disease. (27th April 2018)

Authors:
BUBU, O M; Andrade, A; Hogan, M M; Umasabor-Bubu, O Q; Mukhtar, F; Sharma, R A; Miller, M; Mbah, A; Borenstein, A; Mortimer, J; Kip, K; Morgan, D; Jean-Louis, G; Osorio, R
Journal:
Sleep
Issue:
Volume 41(2018)Supplement 1
Page Start:
A273
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗